Abstract

A REVIEW ON RANOLAZINE AND TRIMETAZIDINE FOR ANGINA PECTORIS

Shangavi V.*, Raagavi E., Nivetha S., Renu Elezabeth Mathew and Nair Anagha Unnikrishnan

.

Abstract

An imbalance between myocardial oxygen supply and demand leads to chronic stable angina pectoris. This blockage of the coronary arteries is fixed. For both patients and medical professionals, chronic angina pectoris poses a frequent and serious problem. The current medical paradigm tries to improve survival by reducing cardiovascular events (vasculoprotective), and/or to enhance quality of life by relieving ischemic symptoms (antianginal). For the treatment of chronic stable angina, Ranolazine and Trimetazidine are now approved.

Keywords: Ranolazine, Trimetazidine, Antianginal, QT prolongation drugs.